Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Yancey Gillespie

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Oncotarget|May 11, 2017
Combination strategies enhance oncolytic virotherapyGregory K Friedman, James M Markert, George Yancey Gillespie
Current Topics in Microbiology and Immunology|March 20, 2019
Cancer Explant ModelsChristian T Stackhouse, George Yancey Gillespie, Christopher D Willey
Seminars in Radiation Oncology|September 19, 2015
Patient-Derived Xenografts as a Model System for Radiation ResearchChristopher D Willey, Ashley N Gilbert, Joshua C Anderson, et al.
Translational Oncology|June 29, 2012
Hypoxia Moderates γ(1)34.5-Deleted Herpes Simplex Virus Oncolytic Activity in Human Glioma Xenoline Primary CulturesGregory K Friedman, Marilyn C Haas, Virginia M Kelly, et al.
World Neurosurgery|November 28, 2018
Stereotactic Placement of Intratumoral Catheters for Continuous Infusion Delivery of Herpes Simplex Virus -1 G207 in Pediatric Malignant Supratentorial Brain TumorsJoshua D Bernstock, Zachary Wright, Asim K Bag, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 13, 2014
Kinomic exploration of temozolomide and radiation resistance in Glioblastoma multiforme xenolinesJoshua C Anderson, Christine W Duarte, Karim Welaya, et al.
Molecular Therapy Oncolytics|October 6, 2015
Pediatric cancer gone viral. Part I: strategies for utilizing oncolytic herpes simplex virus-1 in childrenTimothy P Cripe, Chun-Yu Chen, Nicholas L Denton, et al.
Molecular Therapy Oncolytics|October 6, 2015
Pediatric cancer gone viral. Part II: potential clinical application of oncolytic herpes simplex virus-1 in childrenGregory K Friedman, Elizabeth A Beierle, George Yancey Gillespie, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Oncotarget|May 11, 2017
Combination strategies enhance oncolytic virotherapyGregory K Friedman, James M Markert, George Yancey Gillespie
Current Topics in Microbiology and Immunology|March 20, 2019
Cancer Explant ModelsChristian T Stackhouse, George Yancey Gillespie, Christopher D Willey
Seminars in Radiation Oncology|September 19, 2015
Patient-Derived Xenografts as a Model System for Radiation ResearchChristopher D Willey, Ashley N Gilbert, Joshua C Anderson, et al.
Translational Oncology|June 29, 2012
Hypoxia Moderates γ(1)34.5-Deleted Herpes Simplex Virus Oncolytic Activity in Human Glioma Xenoline Primary CulturesGregory K Friedman, Marilyn C Haas, Virginia M Kelly, et al.
World Neurosurgery|November 28, 2018
Stereotactic Placement of Intratumoral Catheters for Continuous Infusion Delivery of Herpes Simplex Virus -1 G207 in Pediatric Malignant Supratentorial Brain TumorsJoshua D Bernstock, Zachary Wright, Asim K Bag, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 13, 2014
Kinomic exploration of temozolomide and radiation resistance in Glioblastoma multiforme xenolinesJoshua C Anderson, Christine W Duarte, Karim Welaya, et al.
Molecular Therapy Oncolytics|October 6, 2015
Pediatric cancer gone viral. Part I: strategies for utilizing oncolytic herpes simplex virus-1 in childrenTimothy P Cripe, Chun-Yu Chen, Nicholas L Denton, et al.
Molecular Therapy Oncolytics|October 6, 2015
Pediatric cancer gone viral. Part II: potential clinical application of oncolytic herpes simplex virus-1 in childrenGregory K Friedman, Elizabeth A Beierle, George Yancey Gillespie, et al.
Pageof 1